SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX: 1777)

Market Cap	4.17B
Revenue (ttm)	1.22B
Net Income (ttm)	303.94M
Shares Out	44.59M
EPS (ttm)	6.81
PE Ratio	13.75
Forward PE	n/a
Dividend	3.50 (3.74%)
Ex-Dividend Date	Jul 19, 2024

Volume	27,199
Open	93.50
Previous Close	93.60
Day's Range	92.30 - 93.50
52-Week Range	81.70 - 106.50
Beta	0.13
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 6, 2024

About SYN-TECH Chem. & Pharm.

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan and internationally. The company offers products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, antiulcerative, dipeptidyl peptidase 4 inhibitor/antidiabetic, antihyertensive, α- blocker, vasodilator, bronchodilator, anxiolytic, tranquil...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1982
• Employees: 220
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1777

Financial Performance

In 2023, SYN-TECH Chem. & Pharm.'s revenue was 1.11 billion, an increase of 13.02% compared to the previous year's 986.30 million. Earnings were 251.01 million, a decrease of -14.99%.